Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis

Infection

Volumn 41, Issue 4, 2013, Pages 827-831

  Carvalho, A C C ^a   Schumacher, R F ^b   Bigoni, S ^a   Soncini, E ^b   Notarangelo, L ^b   Apostoli, A ^a   Bonfanti, C ^c   Cirillo, D ^d   Mantegani, P ^d   Porta, F ^b   Comelli, M ^e   Matteelli, A ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b San Raffaele Scientific Institute ^*  (Italy)

^c UO Microbiology   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

Children; Interferon gamma release assays; Tuberculosis

Indexed keywords

ISONIAZID;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BURKITT LYMPHOMA; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DISEASE ASSOCIATION; DISEASE COURSE; EWING SARCOMA; FEMALE; HEMATOLOGY; HODGKIN DISEASE; HUMAN; IMMUNE DEFICIENCY; INTERFERON GAMMA RELEASE ASSAY; LUNG TUBERCULOSIS; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MULTIVARIATE ANALYSIS; NEUROBLASTOMA; OCULAR ALBINISM; ONCOLOGY WARD; OSTEOPOROSIS; OSTEOSARCOMA; PRESCHOOL CHILD; SCHOOL CHILD; TUBERCULIN TEST; WISKOTT ALDRICH SYNDROME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; CROSS INFECTION; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; INTERFERON-GAMMA RELEASE TESTS; MALE; MASS SCREENING; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84881117814     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-013-0450-y     Document Type: Article

References (18)

1. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med. 2009;68:2240-6.
2. Ferrara G, Murray M, Winthrop K, et al. Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFα drugs. Curr Opin Pulm Med. 2012;18:233-40.
3. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013;68:745-55.
4. National Institute for Health and Clinical Excellence (NICE). Tuberculosis. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2011. http://www.nice.org.uk/nicemedia/live/ 13422/53642/53642.pdf. Accessed 5 March 2013.
5. Haustein T, Ridout DA, Hartley JC, et al. The likelihood of an indeterminate test result from a whole-blood interferon-gamma release assay for the diagnosis of Mycobacterium tuberculosis infection in children correlates with age and immune status. Pediatr Infect Dis J. 2009;28:669-73.
6. Bergamini BM, Losi M, Vaienti F, et al. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics. 2009;123:e419-24.
7. Bruzzese E, Bocchino M, Assante LR, et al. Gamma interferon release assays for diagnosis of tuberculosis infection in immune-compromised children in a country in which the prevalence of tuberculosis is low. J Clin Microbiol. 2009;47:2355-7.
8. Stefan DC, Dippenaar A, Detjen AK, et al. Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer. Int J Tuberc Lung Dis. 2010;14:689-94.
9. Banfield S, Pascoe E, Thambiran A, Siafarikas A, Burgner D. Factors associated with the performance of a blood-based interferon-γ release assay in diagnosing tuberculosis. PLoS One. 2012;7:e38556.
10. Venables WN, Ripley BD. Modern applied statistics with S. 4th ed. New York: Springer; 2002.
11. Lewinsohn DA, Gennaro ML, Scholvinck L, Lewinsohn DM. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis. 2004;8:658-74.
12. Taylor S, Bryson YJ. Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol. 1985;134:1493-7.
13. Wilson CB, Westall J, Johnston L, Lewis DB, Dower SK, Alpert AR. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest. 1986;77:860-7.
14. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet. 2006;367:1328-34.
15. Herrmann JL, Belloy M, Porcher R, et al. Temporal dynamics of interferon gamma responses in children evaluated for tuberculosis. PLoS One. 2009;4:e4130.
16. Pai M, Joshi R, Dogra S, et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis. 2009;13:84-92.
17. Lee SW, Lee SH, Yim JJ. Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort. Infection. 2012;40:431-5.
18. Connell TG, Davies MA, Johannisen C, et al. Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infect Dis. 2010;10:138.